PKTX (ProtoKinetix) EBITDA Margin %: 0.00% (As of Sep. 2025)


What is ProtoKinetix EBITDA Margin %?

ProtoKinetix PKTX EBITDA Margin % is 0.00% as of Sep. 2025. The stock has 1 warning sign investors should review. Among 945 Biotechnology companies, ProtoKinetix ranks worse than 105820% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ProtoKinetix's EBITDA for the three months ended in Sep. 2025 was $-0.07 Mil. ProtoKinetix's Revenue for the three months ended in Sep. 2025 was $0.00 Mil. Therefore, ProtoKinetix's EBITDA margin for the quarter that ended in Sep. 2025 was 0.00%.

ProtoKinetix  (OTCPK:PKTX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

ProtoKinetix EBITDA Margin % Related Terms

ProtoKinetix EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for ProtoKinetix's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProtoKinetix EBITDA Margin % Chart

ProtoKinetix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ProtoKinetix Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PKTX vs BBLG, JAGX, VBIO: EBITDA Margin % Comparison

For the Biotechnology subindustry, ProtoKinetix's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProtoKinetix EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProtoKinetix's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ProtoKinetix's EBITDA Margin % falls into.


ProtoKinetix EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ProtoKinetix's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-0.311/0
= %

ProtoKinetix's EBITDA Margin % for the quarter that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.072/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
ProtoKinetix (PKTX) has a EBITDA Margin % of 0.00% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ProtoKinetix and its competitors. According to the industry distribution chart, ProtoKinetix ranks #999999 out of 945 companies in the Biotechnology industry.
Is ProtoKinetix's EBITDA Margin % too high?
ProtoKinetix's current EBITDA Margin % is 0.00%. Based on the distribution chart, ProtoKinetix ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does ProtoKinetix's EBITDA Margin % compare to BBLG and JAGX?
According to the Biotechnology industry distribution chart, ProtoKinetix ranks #999999 out of 945 companies for EBITDA Margin %. This places ProtoKinetix in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ProtoKinetix and its competitors. ProtoKinetix's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ProtoKinetix stock overvalued right now?
ProtoKinetix (PKTX) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ProtoKinetix (PKTX), the current EBITDA Margin % is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ProtoKinetix Business Description

Address 109 W Main Street, Dalton, OH, USA, 44618
ProtoKinetix Inc is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins). The AFGP is a compound produced by fish, insects, reptiles, bacteria, and plants that enable survival in freezing temperatures. The company also develops AFGP applications which include regenerative medicine issues including harvesting, processing, storage, and transplanting cells, tissues, and organs and treatments for chronic inflammatory conditions and diseases caused by stress factors, including UV radiation, oxidation, and cryopreservation and hydrogen peroxide.